June 15 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc
* All eleven director nominees elected to board at annual
meeting of shareholders
* Ross, who has been member of board since march 8, 2016 ,
serves on board's nominating and corporate governance committee
* Valeant pharmaceuticals appoints thomas w. Ross, sr. Lead
independent director
Source text for Eikon: ID:nCNWyVTYWa
Further company coverage: VRX.N
(Bengaluru Newsroom: +1-646-223-8780)